Sanofi (NASDAQ:SNY) Announces Quarterly Earnings Results, Meets Expectations

Sanofi (NASDAQ:SNY) posted its quarterly earnings results on Thursday. The company reported $0.70 EPS for the quarter, meeting the consensus estimate of $0.70, Zacks reports. Sanofi had a return on equity of 27.45% and a net margin of 9.96%.

Sanofi Stock Performance

Shares of NASDAQ SNY traded up $2.24 during mid-day trading on Thursday, hitting $54.39. 3,026,519 shares of the company were exchanged, compared to its average volume of 2,572,045. The company has a quick ratio of 0.65, a current ratio of 1.00 and a debt-to-equity ratio of 0.17. The stock has a 50 day simple moving average of $48.99 and a 200-day simple moving average of $52.22. Sanofi has a 1-year low of $45.22 and a 1-year high of $58.97. The firm has a market cap of $138.03 billion, a price-to-earnings ratio of 27.84, a price-to-earnings-growth ratio of 1.19 and a beta of 0.57.

Analyst Ratings Changes

Separately, StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.